🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the manufacturers of acetaminophen, claiming the companies concealed safety concerns that the drug presented to pediatric brain development.

This legal action follows a month after President Donald Trump advocated an unsubstantiated connection between using acetaminophen - referred to as acetaminophen - throughout gestation and autism spectrum disorder in young ones.

The attorney general is suing J&J, which formerly manufactured the drug, the sole analgesic recommended for expectant mothers, and the current manufacturer, which presently makes it.

In a statement, he stated they "betrayed America by profiting off of pain and promoting medication without regard for the dangers."

The company states there is insufficient reliable data tying acetaminophen to autism.

"These corporations misled for generations, intentionally threatening millions to boost earnings," Paxton, from the Republican party, said.

The manufacturer stated officially that it was "deeply concerned by the spread of false claims on the security of paracetamol and the likely effects that could have on the health of women and children in America."

On its online platform, the company also said it had "consistently assessed the applicable studies and there is no credible data that indicates a established connection between using acetaminophen and autism spectrum disorder."

Associations representing medical professionals and health professionals share this view.

ACOG has stated acetaminophen - the key substance in acetaminophen - is among limited choices for expectant mothers to manage discomfort and fever, which can create major wellness concerns if ignored.

"In over twenty years of research on the use of acetaminophen in pregnancy, not a single reputable study has definitively established that the use of acetaminophen in any trimester of gestation causes neurodevelopmental disorders in young ones," the association stated.

The court filing mentions current declarations from the Trump administration in asserting the drug is reportedly hazardous.

Last month, Trump generated worry from health experts when he advised women during pregnancy to "fight like hell" not to use acetaminophen when unwell.

The FDA then released a statement that medical professionals should think about restricting the consumption of Tylenol, while also declaring that "a direct connection" between the medication and autism spectrum disorder in children has not been proven.

The Health Department head Kennedy, who supervises the FDA, had promised in April to undertake "a massive testing and research effort" that would identify the source of autism spectrum disorder in a limited time.

But experts advised that finding a single cause of autism spectrum disorder - thought by researchers to be the result of a complicated interplay of inherited and environmental factors - would be difficult.

Autism spectrum disorder is a type of enduring cognitive variation and condition that affects how individuals encounter and relate to the environment, and is diagnosed using physician assessments.

In his lawsuit, Paxton - who supports Trump who is running for US Senate - claims Kenvue and J&J "deliberately disregarded and sought to suppress the evidence" around paracetamol and autism spectrum disorder.

The lawsuit aims to force the corporations "eliminate any marketing or advertising" that asserts Tylenol is secure for expectant mothers.

The Texas lawsuit parallels the grievances of a collection of guardians of children with autism and ADHD who took legal action against the producers of acetaminophen in two years ago.

A federal judge threw out the legal action, saying studies from the family's specialists was inconclusive.